piracetam has been researched along with vinpocetine in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 5 (20.00) | 18.2507 |
2000's | 10 (40.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Gaál, L; Molnár, P | 1 |
Fischer, W; Kittner, H; Schubert, S | 1 |
Buslo, EA; Galusha, AI; Shevchenko, VA; Zozulia, AA; Zozulia, IS | 1 |
Blaschke, M; Fischer, HD; Rudolph, E; Schmidt, J; Wustmann, C | 1 |
Fischer, HD; Rudolph, E; Schmidt, J; Wustmann, C | 1 |
Milanova, D; Nikolov, R; Nikolova, M | 1 |
Schmidt, J | 1 |
Funk, KF; Schmidt, J | 1 |
Gaál, L; Horváth, C; Molnár, P | 1 |
Otroshchenko, NP | 1 |
Alexy, T; Bíró, Z; Habon, T; Halmosi, R; Horváth, B; Késmárky, G; Márton, Z; Szapáry, L; Tóth, K; Vékási, J | 1 |
Adamek, M; Gabryel, B; Małecki, A; Pudełko, A; Trzeciak, HI | 1 |
Bukanova, JV; Skrebitsky, VG; Solntseva, EI | 1 |
Cahill, L; Gold, PE; Wenk, GL | 1 |
Gaĭkova, ON; Ianishevskiĭ, SN; Onishchenko, LS | 1 |
Gaikova, ON; Onishchenko, LS; Yanishevskii, SN | 1 |
Lagoda, OV; Lokshina, AB; Stakhovskaia, LV; Timerbaeva, SL; Zakharov, VV | 1 |
Filimonov, VA; Kliueva, VN; Kondrasheva, IN | 1 |
Ilavzhagan, G; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P | 1 |
Abdel-Salam, OM; Khadrawy, YA; Salem, NA; Sleem, AA | 1 |
Chukanova, AS; Chukanova, EI; Khodzhamzharov, BÉ | 1 |
Nasr, M; Wahdan, SA | 1 |
Gromova, OA; Torshin, IY | 1 |
1 review(s) available for piracetam and vinpocetine
Article | Year |
---|---|
[Current possibilities of the correction of oxidative stress in acute brain ischaemia].
Topics: Antioxidants; Brain Ischemia; Humans; Oxidative Stress; Pentoxifylline; Piracetam; Reactive Oxygen Species; Vinca Alkaloids | 2012 |
2 trial(s) available for piracetam and vinpocetine
Article | Year |
---|---|
[Psychopharmacotherapy in combine treatment of depressive disorders in patients with brain pathology affected by the Chernobyl Atomic Electric Power Station accident].
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Dothiepin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nootropic Agents; Piracetam; Power Plants; Radioactive Hazard Release; Ukraine; Vinca Alkaloids | 2000 |
[The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Cerebrovascular Disorders; Cognition; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Nootropic Agents; Piracetam; Psychometrics; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2007 |
22 other study(ies) available for piracetam and vinpocetine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of different subtypes of cognition enhancers on long-term potentiation in the rat dentate gyrus in vivo.
Topics: Animals; Cognition; Ergoloid Mesylates; Hippocampus; Male; Neural Pathways; Physostigmine; Piracetam; Rats; Rats, Inbred Strains; Stimulation, Chemical; Time Factors; Vinca Alkaloids | 1992 |
[The action of piracetam, meclofenoxate and vinpocetine in comparative disease models in mice].
Topics: Animals; Anticonvulsants; Electroshock; Meclofenoxate; Mice; Pentylenetetrazole; Piracetam; Postural Balance; Seizures; Vinca Alkaloids | 1991 |
[The treatment of hypertension patients with neurological disorders].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Cerebrovascular Disorders; Diuretics; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Nervous System Diseases; Piracetam; Sodium Chloride Symporter Inhibitors; Vinca Alkaloids | 1990 |
Influence of nootropic drugs on the age-dependent potassium-coupling of transmitter release.
Topics: Aging; Animals; Calcium-Transporting ATPases; Dopamine; Dose-Response Relationship, Drug; Meclofenoxate; Piracetam; Potassium; Psychotropic Drugs; Rats; Rats, Inbred Strains; Synaptosomes; Vasodilator Agents; Vinca Alkaloids | 1990 |
The antihypoxic effect of ethymisole: a comparison with other nootropic drugs.
Topics: Animals; Corpus Striatum; Dopamine; Etimizol; Hypoxia; Imidazoles; In Vitro Techniques; Kinetics; Male; Piracetam; Rats; Rats, Inbred Strains; Vasodilator Agents; Vinca Alkaloids | 1989 |
Anti-hypoxic effect of piracetam and its interaction with prostacyclin.
Topics: Animals; Atmospheric Pressure; Cinnarizine; Drug Synergism; Epoprostenol; Female; Hypoxia; Ischemia; Mice; Mice, Inbred Strains; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Vinca Alkaloids | 1984 |
Nootropic drugs reduce immobility in behavioural despair test in mice.
Topics: Animals; Dihydroergotoxine; Male; Meclofenoxate; Meglumine; Mice; Motor Activity; Nicergoline; Orotic Acid; Piracetam; Psychotropic Drugs; Pyrithioxin; Vinca Alkaloids | 1984 |
Changes of dopamine metabolism by hypoxia and effect of nootropic drugs.
Topics: Animals; Brain; Caudate Nucleus; Diazepam; Dihydroergotoxine; Dopamine; Hypoxia; Meclofenoxate; Orotic Acid; Piracetam; Psychotropic Drugs; Pyrithioxin; Rats; Rats, Inbred Strains; Vinca Alkaloids | 1984 |
The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognition enhancers.
Topics: Animals; Brain Injuries; Cerebellar Nuclei; Ergoloid Mesylates; Long-Term Potentiation; Male; Nootropic Agents; Physostigmine; Piracetam; Rats; Rats, Sprague-Dawley; Septal Nuclei; Vinca Alkaloids | 1994 |
[Scavenger effect of various cerebrovascular drugs].
Topics: Antioxidants; Chromans; Free Radical Scavengers; Hemofiltration; In Vitro Techniques; Neuroprotective Agents; Nootropic Agents; Pentoxifylline; Piracetam; Vinca Alkaloids | 2002 |
Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation.
Topics: Animals; Animals, Newborn; Apoptosis; Astrocytes; Cell Death; Cell Hypoxia; Cells, Cultured; Cytoprotection; Oxygen; Oxygen Consumption; Piracetam; Rats; Rats, Wistar; Vinca Alkaloids | 2002 |
Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons.
Topics: Animals; Calcium Channels; Cell Separation; Dipeptides; Dose-Response Relationship, Drug; Helix, Snails; In Vitro Techniques; Membrane Potentials; Neurons; Nootropic Agents; Patch-Clamp Techniques; Piracetam; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Vinca Alkaloids | 2002 |
The lowdown on Ginkgo biloba.
Topics: Acetylcarnitine; Acetylcholine; Alzheimer Disease; Animals; Antioxidants; Brain; Candy; Cognition; Dietary Sucrose; Dietary Supplements; Donepezil; Ginkgo biloba; Glucose; Humans; Indans; Memory; Neurotransmitter Agents; Phosphatidylcholines; Phosphatidylserines; Piperidines; Piracetam; Plant Extracts; Plant Preparations; Vinca Alkaloids | 2003 |
[Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs].
Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Stroke; Vinca Alkaloids | 2006 |
Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Recovery of Function; Stroke; Vinca Alkaloids | 2008 |
[Vinpotropile in the treatment of cerebral vascular diseases].
Topics: Administration, Oral; Adult; Blood Flow Velocity; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nootropic Agents; Piracetam; Plethysmography, Impedance; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2007 |
Preventive effect of piracetam and vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture.
Topics: Acetylcholinesterase; Animals; Antioxidants; Hippocampus; Hypoxia; In Vitro Techniques; L-Lactate Dehydrogenase; Matrix Metalloproteinases; Neuroprotective Agents; Oxidative Stress; Piracetam; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vinca Alkaloids | 2011 |
Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine.
Topics: Animals; Brain; Male; Models, Biological; Oxidative Stress; Piracetam; Rats; Rats, Sprague-Dawley; Vinca Alkaloids | 2011 |
Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration.
Topics: Administration, Intranasal; Animals; Brain; Drug Compounding; Drug Delivery Systems; Male; Maze Learning; Memory; Memory Disorders; Nanoparticles; Nasal Mucosa; Neuroprotective Agents; Piracetam; Rats; Rats, Wistar; Scopolamine; Sheep; Vinca Alkaloids | 2019 |
[Comparative chemoreactome analysis of the synergism of vinpocetine, piracetam, and cinnarizine molecules].
Topics: Animals; Cinnarizine; Mice; Nootropic Agents; Piracetam; Rats; Vinca Alkaloids | 2021 |